This installment of Supplier Spotlight^® is on STEMCELL Technologies™, who specialize in developing cell culture media, cell separation systems, instruments and other reagents for use in life sciences research across the basic to translational research continuum.

This installment of Supplier Spotlight^® is on QPS, a global leader in clinical and preclinical research.

This installment of Supplier Spotlight^® is on Kemp Proteins, a leading provider of gene-to-protein bioservices.

Stem cells have attracted a great deal of deserved attention due to their lineage-independent characteristics. In other words, they have the potential to be differentiated into a countless number of cell types. Adult stem cells, otherwise known as inducible pluripotent stem cells (iPSCs), are particularly favorable as research tools because they are derived from a patient’s somatic cells such as blood, skin or muscle.

Two global forces are at odds today – the push for “greener” processes and the demand for lower prices for prescription drugs and materials. Governments and corporations across the globe are adopting policy initiatives and driving scientific innovations to promote sustainable technologies, resulting in an explosion of discoveries based on both chemical- and biocatalytic transformations.